￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

Oncology

Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
Ensartinib is more effective than crizotinib in treating ALK-positive non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Lung cancer targeted drug dacomitinib approved for marketing! Can significantly extend the survival time of advanced lung cancer

2025-10-19 11:44:20

Check Details
Is the tuberculosis drug linezolid available in the country? What is the price

2025-10-19 11:44:20

Check Details
Lorlatinib, a new targeted drug for ALK-positive metastatic non-small cell lung cancer (NSCLC), is launched

2025-10-19 11:44:20

Check Details
Lumakras, the first KRAS inhibitor, receives accelerated approval from the FDA for the treatment of non-small cell lung cancer - Kanghule

2025-10-19 11:44:20

Check Details
FDA approves Lumakras as the world's first KRAS targeted therapy! How to buy it?

2025-10-19 11:44:20

Check Details
Rybrevant, the first EGFR20ins targeting drug for lung cancer, has been approved for marketing. Is it effective?

2025-10-19 11:44:20

Check Details
How effective is ramucirumab treatment? Are there any side effects

2025-10-19 11:44:20

Check Details
New drug for lung cancer: MET inhibitor Tepotinib Hydrochloride Tablets Tepmetk

2025-10-19 11:44:20

Check Details
What is the function of larotrectinib? Are the side effects obvious

2025-10-19 11:44:20

Check Details
Can larotrectinib be purchased in domestic pharmacies? What is the price

2025-10-19 11:44:20

Check Details
The launch of AMG510 breaks the situation of no cure for KRAS G12C mutant non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Category
相关知识